Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epoetin Alfa +/- Dexamethasone for Fatigue in Prostate Cancer
NCT00060398Phase 3Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Sep 2004
- Primary completion
- Jun 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of dexamethasone in fatigue and anemia (2 arms), sponsored by Eastern Cooperative Oncology Group. Primary endpoint: Fatigue response as measured by the Functional Assessment of Chronic Illness Therapy Fatigue Subscale at 12 weeks. Started Sep 2004; status: completed.
02
Drugs
dexamethasone
03
Conditions
fatigueanemia
Beyond the preview
Go deeper on NCT00060398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00060398.